Mulmit

Longeveron Inc.Longeveron Inc.

LGVN Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,199,000-23,287,000-22,704,000-1.29
2024-12-312,392,000-16,522,000-15,973,000-2.62
2023-12-31709,000-21,029,000-21,413,000-10.22

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-19Lehr Paul TGeneral Counsel, Secretary286,000
2026-08-19Hajjar Roger Joseph36,000
2026-08-19Soffer Rock36,000
2026-08-19Paletta George A. Jr.36,000
2026-08-19Ungaro Ursula36,000
2026-08-19Desai Arjun JJ36,000
2026-08-19Ascheim Deborah36,000
2026-08-19Cann Leah Rush36,000
2026-08-19Blass DevinCTO & SVP of CMC286,000
2026-08-19Agafonova NataliyaChief Medical Officer286,000
2026-08-19Hare JoshuaChief Scientific Officer286,000
2026-08-17Jhaveri Nirav S.Chief Financial Officer300,000

8-K events

FiledItems
2026-08-24Amendments to charter or bylaws · Regulation FD disclosure · Financial statements and exhibits
2026-08-19Officer or director change · Financial statements and exhibits
2026-08-12Results of operations · Financial statements and exhibits
2026-07-29Other events
2026-07-14Officer or director change · Financial statements and exhibits
2026-07-08Officer or director change
2026-07-06Officer or director change · Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-06-05Officer or director change
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.